Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2024-01-02 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number" and contains standard regulatory tables for reporting changes in share ownership, specifically referencing "TR-1: Standard form for notification of major holdings." This form is used to report when a person's holding in voting rights crosses a specific threshold. This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the content is specific to a major holding change, making MRQ the most precise classification over the general RNS fallback.
2024-01-02 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 2631Y" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content is a "TR-1: Standard form for notification of major holdings," which details changes in share ownership thresholds by an entity (Jefferies Financial Group Inc.). This type of filing, reporting changes in significant shareholdings, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although RNS is present, MRQ is the more specific classification for this content type.
2024-01-02 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "FORM 8.3 - Dechra Pharmaceuticals plc" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of filing relates directly to insider/significant shareholder activity during a takeover bid, which falls under the scope of M&A Activity (TAR) or potentially Director's Dealing (DIRS) if the filer were a director. However, since it is a mandatory disclosure related to a takeover bid (indicated by the reference to the Takeover Code and the structure of Form 8.3), it is most closely aligned with M&A Activity (TAR), which covers merger proposals or takeover bids. While DIRS covers director trades, this is a specific takeover disclosure rule filing. Given the options, TAR is the best fit as it relates to the takeover context, although DIRS is also plausible if the filer was an insider. Since the document details positions and dealings related to an offeror/offeree under the Takeover Code, TAR (M&A Activity) is the most appropriate classification for mandatory takeover-related disclosures.
2024-01-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short notification released via RNS (Regulatory News Service) on December 29, 2023. It explicitly states the purpose is to notify the market of the 'Total Voting Rights' in conformity with DTR 5.6.1R, providing the total number of issued ordinary shares with voting rights (113,905,890). This type of announcement, which relates to the denominator used for shareholder disclosure calculations under FCA rules, is a specific regulatory disclosure. While it is a regulatory filing, the most specific category that covers general regulatory announcements not covered by other specific types (like DIRS, DIV, or SHA) is RNS. However, since the content is specifically about the total number of shares with voting rights, which is a key component of share capital structure disclosure, it could potentially fit under SHA (Share Issue/Capital Change) or be treated as a general regulatory filing (RNS). Given the context of DTR 5.6.1R compliance, which is a standard disclosure requirement, and the lack of an explicit 'Share Issue' or 'Capital Change' event, RNS is the appropriate fallback for this specific regulatory notification type, although it is very close to SHA. Upon review of the definitions, there is no specific code for 'Total Voting Rights' notification. RNS is the best fit for a general regulatory update disseminated via the London Stock Exchange's news service.
2023-12-29 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "FORM 8.3" and references "Rule 8.3 of the Takeover Code (the 'Code')". This form is a Public Opening Position Disclosure/Dealing Disclosure by a person with interests representing 1% or more in the context of a takeover offer (in this case, related to Dechra Pharmaceuticals plc). This type of mandatory disclosure regarding interests in securities during a takeover bid is a specific regulatory filing related to M&A activity, but it is not the M&A announcement itself (TAR) nor a general regulatory filing (RNS). It is a specific disclosure required under takeover rules. Among the provided codes, the closest fit for specific regulatory disclosures related to corporate actions like takeovers, especially those involving director/insider dealings or significant ownership changes during a bid, is often captured under specialized categories. Since there isn't a specific 'Takeover Disclosure' code, and this document details ownership and dealings (similar to DIRS but specific to a takeover context), it falls under the scope of significant ownership changes during a corporate action. However, the most precise category for disclosures related to takeover bids, which often involve significant shareholding changes and dealings, is often grouped with M&A activity (TAR) or treated as a specific regulatory filing. Given the options, this is a highly specific regulatory disclosure related to a potential takeover. Since it details dealings and positions during a takeover context, and it is not a general Director's Dealing (DIRS) but tied to the Code, it is best classified as a specific regulatory filing that is not covered by the other specific codes. Rule 8 disclosures are mandatory filings during a bid. Given the options, 'RNS' (Regulatory Filings - general fallback) is the safest classification if a specific 'Takeover Disclosure' code is missing, but let's re-evaluate against 'DIRS' and 'TAR'. It is not a general Director's Dealing (DIRS) as it's tied to the Takeover Code. It is not the M&A announcement (TAR). Therefore, it fits best as a specific regulatory filing that doesn't match other categories, making RNS the appropriate fallback.
2023-12-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the 'RNS Number' header and contains the standard boilerplate text referencing RNS, the news service of the London Stock Exchange, and the Financial Conduct Authority (FCA). The content itself is a 'TR-1: Standard form for notification of major holdings' filed by JPMorgan Chase & Co. regarding an acquisition/disposal of voting rights. This type of mandatory disclosure regarding changes in significant share ownership thresholds falls directly under the definition of Major Shareholding Notification (MRQ). It is not a full financial report (10-K, IR) or a general announcement (RNS), but a specific regulatory filing about ownership changes.
2023-12-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.